• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ:SNOA)

2.930 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Sonoma Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
February 10, 2026
Via ACCESS Newswire
News headline image
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
November 13, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
November 06, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
November 04, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
October 14, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results
February 05, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results
November 07, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results
August 08, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
October 07, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 25, 2025
Via ACCESS Newswire
News headline image
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
August 26, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
August 13, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
August 07, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
June 17, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
April 22, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency (MHRA)
March 10, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando
February 25, 2025
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices
December 05, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States
November 21, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel
November 11, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
October 31, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada
October 22, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences
October 21, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule
September 19, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance with Expanded Indications for Over-the-Counter Microcyn(R)-Based Solution
September 17, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals and EMC Pharma Announce Collaboration to Co-market an Expanded Eye Care Product Line
September 11, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Split of Outstanding Common Stock
August 28, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals and MicroSafe Group Announce that Nanocyn(R) Disinfectant & Sanitizer has been Approved by the Australian TGA as Effective Against Candida auris and C-Diff
August 26, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Announces Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in the United States
August 21, 2024
Via ACCESSWIRE
News headline image
Sonoma Pharmaceuticals Celebrates 20 Years of Selling Wound Care Products in Europe and Announces New Distributor in Ukraine
July 09, 2024
Via ACCESSWIRE
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap